<\/p>\n\n
Treister N, Schubert MS, Fall-Dickson JM. Oral chronic graft vs host disease. In: Vogelsang GB, Pavletic SZ, eds. Chronic Graft-Versus-Host Disease: Interdisciplinary Management. New York: Cambridge University; 2009:182\u2013198.<\/p>\n\n
Mays JW, Fassil H, Edwards DA, Pavletic SZ, Bassim CW. Oral chronic graftversus-host disease: current pathogenesis, therapy, and research. Oral Dis. 2013;19(4):327\u2013346.<\/p>\n\n
Jagasia M, Arora M, Flowers ME, et al. Risk factors for acute GVHD and survival after hematopoietic cell transplantation. Blood 2012;119(1):296\u2013307.<\/p>\n\n
Atkinson K, Horowitz MM, Gale RP, et al. Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Blood 1990;75(12):2459\u201364.<\/p>\n\n
Kuten-Shorrer M, Woo SB, Treister NS. Oral graft-versus-host disease. Dent Clin North Am. 2014;58(2):351-68.<\/p>\n\n
Blazar BR, Murphy WJ, Abedi M. Advances in graft-versus-host disease biology and therapy. Nat Rev Immunol 2012;12(6):443\u201358.<\/p>\n\n
Weiden PL, Sullivan KM, Flournoy N, et al. Antileukemic effect of chronic graftversus-host disease: contribution to improved survival after allogeneic marrow transplantation. N Engl J Med 1981;304(25):1529\u201333.<\/p>\n\n
Schubert MM, Correa ME. Oral graft-versus-host disease. Dent Clin North Am 2008;52(1):79\u2013109 viii-ix.<\/p>\n\n
Treister NS, Cook EF Jr, Antin J, et al. Clinical evaluation of oral chronic graftversus-host disease. Biol Blood Marrow Transplant 2008;14(1):110\u20135.<\/p>\n\n
Treister N, Duncan C, Cutler C, et al. How we treat oral chronic graft-versus-host disease. Blood 2012;120(17):3407\u201318.<\/p>\n\n
Jagasia MH, Greinix HT, Arora M, et al. National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus host disease: I. The 2014 Diagnosis and Staging Working Group report. Biol Blood Marrow Transplant 2015;21(3):389\u2013401.e1.<\/p>\n\n
Filipovich AH, Weisdorf D, Pavletic S, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graftversus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005;11(12):945\u201356.<\/p>\n\n
Mielcarek M, Martin PJ, Leisenring W, et al. Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation. Blood 2003;102(2):756\u201362.<\/p>\n\n
Elad S, Aljitawi O, Zadik Y. Oral graft-versus-host disease: a pictorial review and a guide for dental practitioners. Int Dent J. 2020 Jun 28. doi: 10.1111\/idj.12584.<\/p>\n\n
Przepiorka D, Weisdorf D, Martin P, et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995;15(6):825\u20138.<\/p>\n\n
Dignan FL, Clark A, Amrolia P, et al. Diagnosis and management of acute graftversus-host disease. Br J Haematol 2012;158(1):30\u201345.<\/p>\n\n
Shulman HM, Sale GE, Lerner KG, et al. Chronic cutaneous graft-versus-host disease in man. Am J Pathol 1978;91(3):545\u201370.<\/p>\n\n
Lee SJ, Vogelsang G, Flowers ME. Chronic graft-versus-host disease. Biol Blood Marrow Transplant 2003;9(4):215\u201333.<\/p>\n\n
Imanguli MM, Alevizos I, Brown R, et al. Oral graft-versus-host disease. Oral Dis 2008;14(5):396\u2013412.<\/p>\n\n
Meier JK, Wolff D, Pavletic S, et al. Oral chronic graft-versus-host disease: report from the International Consensus Conference on Clinical Practice in cGVHD. Clin Oral Investig 2011;15(2):127\u201339.<\/p>\n\n
Pavletic SZ, Martin P, Lee SJ, et al. Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report. Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow. Transplantation 2006;12(3):252\u201366.<\/p>\n\n
Lee SJ, Wolff D, Kitko C, et al. Measuring therapeutic response in chronic graft-versus-host disease. national institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group Report. Biol Blood Marrow Transpl 2015;21(6):984\u201399.<\/p>\n\n
Margaix-Mu\u00f1oz M, Bag\u00e1n JV, Jim\u00e9nez Y, Sarri\u00f3n MG, Poveda-Roda R. Graft-versus-host disease affecting oral cavity. A review. J Clin Exp Dent. 2015;7(1):e138-45.<\/p>\n\n
Shulman HM, Kleiner D, Lee SJ, et al. Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology working group report. Biol Blood Marrow Transplant 2006;12(1):31\u201347.<\/p>\n\n
Fall-Dickson JM, Cordes S, Berger AM. Oral complications. In: DeVita VT, Lawrence TS, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. 11th ed. Philadelphia: Wolters Kluwer; 2019:2094\u20132108.<\/p>\n\n
Jaglowski SM, Blazar BR. How ibrutinib, a B-cell malignancy drug, became an FDA-approved second-line therapy for steroid-resistant chronic GVHD. Blood Adv. 2018;2(15):2012\u20132019.<\/p>\n\n
Fall-Dickson JM, Pavletic SZ, Mays JW, Schubert MM. Oral Complications of Chronic Graft-Versus-Host Disease. J Natl Cancer Inst Monogr. 2019;2019(53): lgz007.<\/p>\n\n
Treister N, Li S, Lerman MA, et al. Narrow-band UVB phototherapy for management of oral chronic graft-versus-host disease. Photodermatol Photoimmunol Photomed 2015;31(2):75\u201382.<\/p>\n\n
Elad S, Jensen SB, Raber-Durlacher JE, et al. Clinical approach in the management of oral chronic graft-versus-host disease (cGVHD) in a series of specialized medical centers. Support Care Cancer 2015;23(6):1615\u201322.<\/p>\n\n
Carpenter PA, Kitko CL, Elad S, et al. National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report. Biol Blood Marrow Transpl 2015;21(7):1167\u201387.<\/p>\n\n
Elad S, Zadik Y, Zeevi I, et al. Oral cancer in patients after hematopoietic stem-cell transplantation: long-term follow-up suggests an increased risk for recurrence. Transplantation 2010;90(11):1243\u20134.<\/p>\n
<\/div><\/div>\n","protected":false},"excerpt":{"rendered":"
Maladie du greffon contre l’h\u00f4te buccale L’objectif de cet outil d’apprentissage en ligne est de pr\u00e9senter aux lecteurs des informations sur l’\u00e9pid\u00e9miologie, les caract\u00e9ristiques cliniques, le diagnostic et la prise en charge de la maladie du greffon contre l’h\u00f4te. La maladie du greffon contre l’h\u00f4te (GVHD) est une affection immunologique qui se d\u00e9veloppe apr\u00e8s une […]<\/p>\n","protected":false},"author":1,"featured_media":448,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"footnotes":""},"categories":[10],"tags":[],"jetpack_featured_media_url":"https:\/\/opmdcare.com\/wp-content\/uploads\/oral-gvhd.jpeg","_links":{"self":[{"href":"https:\/\/opmdcare.com\/wp-json\/wp\/v2\/posts\/2877"}],"collection":[{"href":"https:\/\/opmdcare.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/opmdcare.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/opmdcare.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/opmdcare.com\/wp-json\/wp\/v2\/comments?post=2877"}],"version-history":[{"count":1,"href":"https:\/\/opmdcare.com\/wp-json\/wp\/v2\/posts\/2877\/revisions"}],"predecessor-version":[{"id":2878,"href":"https:\/\/opmdcare.com\/wp-json\/wp\/v2\/posts\/2877\/revisions\/2878"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/opmdcare.com\/wp-json\/wp\/v2\/media\/448"}],"wp:attachment":[{"href":"https:\/\/opmdcare.com\/wp-json\/wp\/v2\/media?parent=2877"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/opmdcare.com\/wp-json\/wp\/v2\/categories?post=2877"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/opmdcare.com\/wp-json\/wp\/v2\/tags?post=2877"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}